Automated insulin delivery with the MiniMed ™ 780G system reduces burden by improving sleep and glycaemic control overnight

Diabetes Obesity and Metabolism 2026

View at publisher
Authors: Jennifer J. F. McVean, Fang Niu, Margaret Liu, Arcelia Arrieta, NAVEEN MATHEW NATHAN SATHIYANATHAN, John Shin, Robert A. Vigersky
DOI: 10.1111/dom.70380
Cited by: 2
References: 13

Abstract

The MiniMed™ 780G system includes technology developed by DreaMed Diabetes (Petah Tikvah, Israel). All authors are employees of Medtronic Diabetes. The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1111/dom.70380. The proprietary datasets generated and analysed for the current study are not publicly available but can be made available from the corresponding author upon reasonable request.

Fields of Study & Subjects

Diabetes Management and Research Mobile Health and mHealth Applications Hyperglycemia and glycemic control in critically ill and hospitalized patients

Publication details

Journal / source
Diabetes Obesity and Metabolism
Publisher
Wiley
Volume
28
Issue
3
Pages
2456–2460
Publication date
8 January 2026
Language
EN